home / stock / ymtx / ymtx news

YMTX News and Press, Yumanity Therapeutics Inc. From 08/04/22

Stock Information
Company Name: Yumanity Therapeutics Inc.
Stock Symbol: YMTX
Market: NASDAQ
Menu
YMTX YMTX Quote YMTX Short YMTX News YMTX Articles YMTX Message Board
Get YMTX Alerts

News, Short Squeeze, Breakout and More Instantly...
YMTX - Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments

BOSTON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, Inc. (“Yumanity” or the “Company”) (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerativ...
YMTX - Mirati, CymaBay top healthcare gainers; Verastem, Delcath lead losers' pack

Gainers: Mirati Therapeutics (MRTX) +23%. CymaBay Therapeutics (CBAY) +16%. Veru (VERU) +9%. Kodiak Sciences (KOD) +8%. Allarity Therapeutics (ALLR) +7%. Losers: Verastem (VSTM) -12%. Delcath Systems (DCTH) -11%. Vicarious Surgical (RBOT) -8%. CEL-...

YMTX - Target, Coupa Software, FLEX LNG among premarket losers' pack

Target (TGT) -8% after warning on hit to margins from clearing inventory. FLEX LNG (FLNG) -7%. Globus Maritime (GLBS) -7% on Q1 earnings release. Yumanity Therapeutics (YMTX) -6%. AeroClean Technologies (AERC) -7%. FTC Solar (FTCI) -5%. Coupa Software (COUP) -4% ...

YMTX - Best Penny Stocks to Buy That Exploded Today? 3 to Watch

3 Penny Stocks That Exploded During Trading Today If you’re looking for the best penny stocks to buy, there are plenty of options to choose from. But, investors need to make sure that the companies on their lists, are penny stocks that are worth investing in. Here are a few t...
YMTX - VIEW, UONE and STRY among mid-day movers

Gainers: Aero Clean Technologies (AERC) +58%. DiDi Global (DIDI) +39%. Yumanity Therapeutics (YMTX) +31%. Pineapple Energy (PEGY) +25%. View (VIEW) +26%. ATIF Holdings (ATIF) +26%. The Arena Group Holdings (AREN) +25%. Cerberus Cyber Sentinel (CISO) +23%. FTC Solar (FTCI) +23%. Kanzhun (BZ) +...

YMTX - WWDC 2022: 11 Things to Know About This Year's Apple Developers Event

InvestorPlace - Stock Market News, Stock Advice & Trading Tips WWDC 2022 starts today with a keynote presentation. Apple is expected to show off iOS updates today. We may also get a look at its AR plans. Source: Vytautas Kielaitis / Shutterstock.com WWDC 2022 kicks off to...

YMTX - Yumanity, Babylon top healthcare gainers; while Praxis, eFFECTOR lead losers' pack

Gainers:  Yumanity Therapeutics YMTX +46%. Babylon (BBLN) +11%. Sema4 (SMFR) +11%. Nano-X Imaging (NNOX) +10%. Satsuma Pharmaceuticals (STSA) +10%. Losers: Praxis Precision Medicines PRAX -63%. eFFECTOR Therapeutics (EFTR) -20%. Pear Therapeutics (PEAR) ...
YMTX - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips DiDi Global (NYSE: DIDI ) leads our gainers on probe reports. Amazon (NASDAQ: AMZN ) tops the losers as its stock splits. Plenty of other shares are rising and falling this morning. Source: Shutterstoc...

YMTX - Yumanity stock soars 46% on all-stock merger with Kineta; lead product sale to J&J for $26M

Yumanity Therapeutics (NASDAQ:YMTX) is selling its lead clinical-stage product YTX-7739 to Johnson & Johnson (NYSE:JNJ) for $26M in cash and is merging with privately-held Kineta in an all-stock transaction. Yumanity said it is selling YTX-7739 and its unpartnered disc...

YMTX - Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions

Yumanity Therapeutics, Inc. to sell its clinical-stage product candidate YTX-7739 as well as its unpartnered discovery-stage neuroscience product candidates and targets to Janssen Pharmaceutica NV in a $26 million cash transaction Kineta, Inc., a private immuno-oncology company,...
Previous 10 Next 10